Malik Fady Ibraham bought CYTK
December 2, 2025 · Form 4 insider transaction
Malik Fady Ibraham bought 2,200 shares of Cytokinetics, Incorporated at $10.60 per share, a transaction worth $23.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,200
Price
$10.60
Total value
$23.3K
InsiderMalik Fady Ibraham
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 2, 2025
Filing dateDecember 2, 2025
Shares owned after142,810
OwnershipDirect
10b5-1 planNo
AmendedNo